Thalys Medical Technology Group Corporation (SHA:603716)
33.95
+0.85 (2.57%)
Aug 29, 2025, 3:00 PM CST
SHA:603716 Revenue
Thalys Medical Technology Group had revenue of 287.43M CNY in the quarter ending March 31, 2025, a decrease of -40.75%. This brings the company's revenue in the last twelve months to 1.61B, down -21.21% year-over-year. In the year 2024, Thalys Medical Technology Group had annual revenue of 1.81B, down -9.74%.
Revenue (ttm)
1.61B
Revenue Growth
-21.21%
P/S Ratio
3.94
Revenue / Employee
1.29M
Employees
1,246
Market Cap
6.35B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.81B | -195.45M | -9.74% |
Dec 31, 2023 | 2.01B | -302.50M | -13.10% |
Dec 31, 2022 | 2.31B | -290.92M | -11.19% |
Dec 31, 2021 | 2.60B | 474.08M | 22.30% |
Dec 31, 2020 | 2.13B | 294.70M | 16.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |